Juno Biomedical, Inc. About Us ... “Juno Biomedical's technology opens a new frontier in treating currently untreatable and disabling conditions such as stroke."
Learn about working at Juno Biomedical, Inc.. Join LinkedIn today for free. See who you know at Juno Biomedical, Inc., leverage your professional network, and ...
Feb 19, 2018 ... Responsible Party: Juno Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT03436771 History of Changes. Other Study ID Numbers: LTFU001.
For the fiscal year ended December 31, 2016. OR ... Juno Therapeutics, Inc. ...... application for filing, or, if the application relates to an unmet medical need in a ...
We're on a quest to radically change the course of medicine by aligning our investments in research, manufacturing & people to change the way we treat ...
Juno is planning to evaluate multiple product candidates in Phase 1 trials for common types of relapsed or refractory (R/R) B cell NHL of both aggressive and ...
Dec 3, 2013 ... The cancer research company is a spin out of the Fred… ... long-term remissions and reduce or eliminate the need for debilitating surgery, radiation and chemotherapy. ... Juno Therapeutics Inc., a new biotechnology company focused on .... on cancer treatment and biomedical research around the world.
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the ... UNO THERAPEUTICS, INC. ... Juno Therapeutics acquired by Celgene.
Nov 23, 2016 ... Juno Therapeutics said it has suspended a clinical trial of a cancer drug ... The company's “Rocket” trial for B cell acute lymphoblastic leukemia — or ... neurotoxicity or cerebral edema,” Chief Medical Officer Mark Gilbert said ...